Vaccination for 12-14 age group likely to start by March: NTAGI chief

The Covid vaccination programme is set to start for the 12-14 age group from February-end, Dr N K Arora, chairman of the Covid-19 working group of the National Technical Advisory Group on Immunisation told TOI on Sunday. Adolescent vaccination is making impressive strides across the country.

Umesh Isalkar
  • Updated On Jan 17, 2022 at 06:24 AM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
PUNE: The Covid vaccination programme is set to start for the 12-14 age group from February-end, Dr N K Arora, chairman of the Covid-19 working group of the National Technical Advisory Group on Immunisation told TOI on Sunday.

Adolescent vaccination is making impressive strides across the country. A total of 3.31 crore children in the age bracket of 15 to 17 years have already received their first dose, accounting for almost 45% coverage, just 13 days into the drive on January 3 this year.

“We aim to cover all the 7.4 crore adolescents in the 15-17 age bracket with the first dose by January-end so that we can start vaccinating them with the second dose from early February and finish the second dose by February-end. We want to start vaccinating children between 12 and 14 years from February-end or early March,” Dr Arora said.
Children aged 12 to 17 are quite like adults, experts said. “So, the decision was mainly taken to protect the adolescents in the 15-17 group first. Once their full vaccination is done, the government will take up the policy decision to include the next age group, which is the 12-14 bracket,” he added.

Advt
Experts hail move of jabs for 12-14 age group from February
Dr N K Arora, chairman of the Covid-19 working group of the National Technical Advisory Group on Immunisation on Sunday said that the drive is set to start for the 12-14 age group from February-end. Immunising adolescents is important as they are mobile. They go to schools, colleges, mingle and run a high risk of acquiring infection, particularly due to the fast-paced Omicron variant of the coronavirus. This is why the government prioritised this group from the under-18 category, experts said.

“Expanding the ambit of children’s vaccination is a welcome step. The government should also consider prioritising vaccination of comorbid children in the 5-14 age group,” said Dr Pramod Jog, former national president of the Indian Academy of Paediatrics.

Bharat Biotech’s Covaxin, being given to adolescents (15-18 group) has the Centre’s Emergency Use Approval for children in the 2-18 group. The vaccine has been found safe and effective in children’s trials in the 2-18 age bracket.
  • Published On Jan 17, 2022 at 06:24 AM IST
Be the first one to comment.
Comment Now

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App